Medicated shampoos for the treatment of seborrheic dermatitis

Journal of Drugs in Dermatology

Volumn 7, Issue 7, 2008, Pages 699-703

  Waldroup, Whitney ^a   Scheinfeld, Noah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; COSMETIC; KERATOLYTIC AGENT; TEA TREE OIL;

HUMAN; REVIEW; SEBORRHEIC DERMATITIS; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; DERMATITIS, SEBORRHEIC; HAIR PREPARATIONS; HUMANS; KERATOLYTIC AGENTS; SCALP DERMATOSES; TEA TREE OIL;

EID: 52449108003     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Burton JL, Pye PJ: Seborrhoea is not a feature of seborrhoeic dermatitis. Br Med J. 1983;286:1169.
2. Smith KJ, Skeleton, HO, Yeager J, et al for the Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Cutaneous findings in HIV-1 positive patients: a 42 month prospective study. J Am Acad Dermatol. 1994;31:746-754.
3. Plewig G, Jansen T. Seborrheic dermatitis. In: Wolff K, Lowell A, Goldsmith LA, et al, eds. Fitzpatrick's Dermatology in General Medicine, 7th ed. McGraw Hill, 2008.
4. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1:75-80.
5. McGinley KJ, Leyden JJ, Marples BN, Klingman AM. Quantitative microbiology in non-dandruff and seborrheic dermatitis. J Am Acad Dermatol. 1975;64:401-404.
6. Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol. 2004;5:417-422.
7. Sohnle PG, Collins-Lech C: Activation of complement by Pityrosporum orbiculare. J Invest Dermatol. 1983;80:93.
8. Ive FA. An overview of experience with ketoconazole shampoo. Br J Clin Pract. 1991;45:279-284.
9. Abeck D, Loprox Shampoo Dosing Study Group. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage. Int J Dermatol. 2004;43 (Suppl):13-16.
10. Jue SG, Dawson GW, Brogden RN, Ciclopirox Olamine 1% Cream. A preliminary review of its antimicrobial activity and therapeutic use. Drugs. 1985;29:330-341.
11. Rosen T, Schell BJ, Orengo I. Anti-inflammatory activity of antifungal preparations. Int J Dermatol. 1997;36:788-792.
12. Roques C, Brousse S, Panizzutti C. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains. Mycopathologia. 2006;162:395-400.
13. Gupta AK, Nicol K. The use of sulfur in dermatology. J Drugs Dermatol. 2004;3:427-431.
14. Federal Register. OTC Drug Products for the Control of Dandruff, Seborrheic Dermatitis, and Psoriasis (358); Establishment of a Monograph (ANPR). P 54646. December 3, 1982.
15. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol. 1984;111:235-242.
16. Lebwohl M, Plott T. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol. 2004;43 (Suppl):17-20.
17. van Schooten FJ, Moonen EJC, Rhijnsburger E, et al. Epidemiological studies indicate that occupational exposure to coal tar may lead to an increased risk of lung, scrotum and skin cancer. Lancet. 1994;344:1505-1506.
18. Goldman WJ. Carcinogenicity of coal-tar shampoo. Lancet. 1995;345:326.
19. Dobrev H, Zissova L. Effect of ketoconazole 2% shampoo on scalp sebum level in patients with seborrhoeic dermatitis. Acta Derm Venereol. 1997;77:132-134.
20. Green CA, Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole. Br J Dermatol. 1987;116:217-221.
21. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 1995;132:441-445.
22. Segal R, David M, Ingber A, et al. Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venereol. 1992;72:454-455.
23. Zeharia A, Mimouni M, Fogel D. Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Ped Dermatol. 1996;13:151-153.
24. Schuster S, Meynadier J, Kerl H, Nolting S. Treatment and prophylaxis of seborrheic dermatitis with antipityrosporal Ciclopirox 1% shampoo. Archives of Dermatology. 2005;141:47-52.
25. Saple DG, Ravichandran G, Desai A. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff - a postmarketing study. J Indian Med Assoc. 2000;98:810-811.
26. Lorette G, Ermosilla V. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. Eur J Dermatol. 2006;16:558-564.
27. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29:1008-1012.
28. Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) andketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat. 2007;18:88-96.
29. Squire RA, Goode K. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis. J Dermatolog Treat. 2002;13:51-60.
30. Pierard-Franchimont C, Goffin V, Decroix J, Pierard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002;15:434-441.
31. Reygagne P, Poncet M, Sidou F, Soto P. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. Cutis. 2007;79:397-403.
32. Sawleshwarkar SN, Salgaonkar V, Oberai C. Multicenter, open-label, non-comparative study of a combination of polytar andzinc pyrithione shampoo in the management of dandruff. Indian J Dermatol Venereol Leprol. 2004;70:25-28.
33. Roelofzen JH, Aben KK, van de Valk PG, et al. Cole tar in dermatology. J Dermatol Treat. 2007;18:329-324.
34. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol. 2002;47:852-855.
35. Robinson JR, Gauger LJ. Dermatitis, dry skin, dandruff and psoriasis products. In: Nonprescription products, formulations and features. Washington DC, American Pharmaceutical Association. 1986;30:597-623.
36. Fishman HC. Seborrheic dermatitis: practical therapy. Cutis. 1977;20:724-726.
37. Brodell RT, Cooper KD. Therapeutic shampoos. In: Wolverton SE, ed. Comprehensive dermatologic drug therapy. Philadelphia, PA: WB Saunders Company; 2001:647-658.